| scholarly article | Q13442814 |
| P2093 | author name string | Gang Liu | |
| Guiting Lin | |||
| Tom F Lue | |||
| Ching-Shwun Lin | |||
| Guifang Wang | |||
| Li-Jun Yang | |||
| Lung-Ji Chang | |||
| P2860 | cites work | Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan | Q28237502 |
| Adipose-derived stem cells for regenerative medicine | Q28301763 | ||
| Global and societal implications of the diabetes epidemic | Q29614551 | ||
| Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes | Q29619192 | ||
| Insulin targeting to the regulated secretory pathway after fusion with green fluorescent protein and firefly luciferase | Q32073156 | ||
| Type 2 diabetes: an overview. | Q33701883 | ||
| Defining stem and progenitor cells within adipose tissue | Q33834898 | ||
| Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells | Q33944612 | ||
| Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. | Q34491740 | ||
| Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells | Q34592597 | ||
| Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin | Q35102692 | ||
| Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells | Q36076469 | ||
| Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1- and Pdx1-VP16 mediated by lentiviral vectors | Q36158409 | ||
| In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow | Q36173435 | ||
| Multipotential differentiation of adipose tissue-derived stem cells | Q36291544 | ||
| Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse | Q36403623 | ||
| Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies | Q36786235 | ||
| Stem cells from adipose tissue allow challenging new concepts for regenerative medicine | Q36828800 | ||
| Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy | Q37094023 | ||
| Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes | Q38450350 | ||
| The safety of liposuction: results of a national survey | Q40618264 | ||
| Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. | Q41678876 | ||
| Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism | Q42828277 | ||
| Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). | Q43869405 | ||
| Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial | Q44333576 | ||
| Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid | Q44564028 | ||
| Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats | Q44614314 | ||
| In vitro differentiation of human adipose tissue-derived stem cells into cells with pancreatic phenotype by regenerating pancreas extract | Q46412665 | ||
| In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract | Q46432427 | ||
| International trial of the Edmonton protocol for islet transplantation. | Q54032399 | ||
| Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells | Q64377305 | ||
| Islet cell transplantation today | Q80059639 | ||
| Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation | Q80576417 | ||
| Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells | Q81598974 | ||
| Role of Pax4 in Pdx1-VP16-mediated liver-to-endocrine pancreas transdifferentiation | Q83864585 | ||
| P433 | issue | 10 | |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 1399-1406 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Stem Cells and Development | Q15724421 |
| P1476 | title | Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. | |
| P478 | volume | 18 |
| Q33759539 | Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia |
| Q35715553 | Adipose tissue stem cells meet preadipocyte commitment: going back to the future |
| Q26849284 | Adipose tissue stem cells: the great WAT hope |
| Q53652126 | Adipose-derived stem cells from both visceral and subcutaneous fat deposits significantly improve contractile function of infarcted rat hearts. |
| Q33614702 | Adult stem cells as a renewable source of insulin-producing cells |
| Q38332629 | Applicability of adipose-derived stem cells in type 1 diabetes mellitus. |
| Q37692502 | CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success? |
| Q40970245 | Cell replacement and regeneration therapy for diabetes |
| Q36295339 | Chitosan-assisted differentiation of porcine adipose tissue-derived stem cells into glucose-responsive insulin-secreting clusters. |
| Q90387735 | Co-culture with TM4 cells enhances the proliferation and migration of rat adipose-derived mesenchymal stem cells with high stemness |
| Q44293731 | Comparative phenotypic and molecular characterization of porcine mesenchymal stem cells from different sources for translational studies in a large animal model |
| Q34797310 | Correction of Diabetic Hyperglycemia and Amelioration of Metabolic Anomalies by Minicircle DNA Mediated Glucose-Dependent Hepatic Insulin Production |
| Q28078407 | Current progress of human trials using stem cell therapy as a treatment for diabetes mellitus |
| Q89633927 | Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells |
| Q44783451 | Efficacy of BloodSTOP iX, surgicel, and gelfoam in rat models of active bleeding from partial nephrectomy and aortic needle injury |
| Q38932832 | Efficient and sustained IGF-1 expression in the adipose tissue-derived stem cells mediated via a lentiviral vector |
| Q64111171 | Expansion of Murine MSC Impairs Transcription Factor-Induced Differentiation into Pancreatic -Cells |
| Q36257063 | From bench to bedside: use of human adipose-derived stem cells. |
| Q42149222 | Generation of Islet-like Cell Aggregates from Human Adipose Tissue-derived Stem Cells by Lentiviral Overexpression of PDX-1 |
| Q35964770 | Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis |
| Q37824621 | Human adipose-derived stem cells: potential clinical applications in surgery. |
| Q26998695 | Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications |
| Q42655188 | Immortalized porcine mesenchymal cells derived from nasal mucosa, lungs, lymph nodes, spleen and bone marrow retain their stemness properties and trigger the expression of siglec-1 in co-cultured blood monocytic cells |
| Q34229909 | Improving power of genome-wide association studies with weighted false discovery rate control and prioritized subset analysis |
| Q38334043 | Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes |
| Q38374569 | Mesenchymal stem cells in the treatment of type 1 diabetes mellitus |
| Q36578235 | PDX1-engineered embryonic stem cell-derived insulin producing cells regulate hyperglycemia in diabetic mice |
| Q34117889 | Promoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetes |
| Q21090034 | RNAa is conserved in mammalian cells |
| Q26752205 | Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells |
| Q41826004 | Regenerative repair of damaged meniscus with autologous adipose tissue-derived stem cells |
| Q42930729 | Roles of the co-culture of human umbilical cord Wharton's jelly-derived mesenchymal stem cells with rat pancreatic cells in the treatment of rats with diabetes mellitus |
| Q91876802 | Small extracellular vesicles from human adipose-derived stem cells attenuate cartilage degeneration |
| Q42175860 | Stress augments insulin resistance and prothrombotic state: role of visceral adipose-derived monocyte chemoattractant protein-1. |
| Q47696722 | The Journey of Islet Cell Transplantation and Future Development. |
| Q40786098 | The adipose-derived stem cell: looking back and looking ahead |
| Q37790311 | The potential of adipose stem cells in regenerative medicine. |
| Q38262028 | The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissue |
| Q51510975 | Transplantation of adipose tissue protects BB/OK rats from type 1 diabetes development. |
| Q40321403 | Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study |
| Q53181372 | Unwinding the Novel Genes Involved in the Differentiation of Embryonic Stem Cells into Insulin-Producing Cells: A Network-Based Approach. |
Search more.